Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study
| Autor: | Teun P. van Es, J. Wouter Jukema, Erik Bruijns, Henk K. van Halteren, Henk W. O. Roeters van Lennep, Aeilko H. Zwinderman, Job A. J. de Boo, Anton P. van de Woestijne, Arnoud van der Laarse, Anho Liem, Dirk J. van Veldhuisen |
|---|---|
| Přispěvatelé: | Amsterdam Public Health, Epidemiology and Data Science, Faculteit Medische Wetenschappen/UMCG, Cardiovascular Centre (CVC) |
| Jazyk: | angličtina |
| Rok vydání: | 2009 |
| Předmět: |
Acute coronary syndrome
medicine.medical_specialty Myocardial Infarction Pilot Projects Infarct size CARDIOPROTECTION ERYTHROPOIETIN PROTECTS Internal medicine Humans Medicine In patient Prospective Studies Myocardial infarction Erythropoietin Cardioprotection business.industry Significant difference Increased systolic blood pressure medicine.disease Recombinant Proteins Epoetin Alfa Injections Intravenous Cardiology Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | International journal of cardiology, 131(2), 285-287. Elsevier Ireland Ltd International Journal of Cardiology, 131(2), 285-287. ELSEVIER IRELAND LTD |
| ISSN: | 0167-5273 |
| Popis: | A pilot study was performed to determine the effect of 40,000 IU Epo on myocardial damage in 51 patients with non-ST segment elevation acute coronary syndrome (non-STE ACS). No significant difference in myocardial damage was found, but an increased systolic blood pressure was noticed. (C) 2007 Elsevier Ireland Ltd. All rights reserved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect